None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Index patients with serologically confirmed Hepatitis-C viral infection 2. Family members of Index Patients with age above 5 years, staying together in same house 3. Written informed consent from adult family members (age ≥ 18 years) and assent from pediatric members in addition for participation in the study 4. Control Patients with serological evidence of Hepatitis C without any family members infected with Hepatitis C 5. Willing to provide feedback on questionnaire for identifying risk factors 6. Willing to provide blood sample for serological analysis and other laboratory analysis
Exclusion criteria
Exclusion criteria: 1. Index Patients, their Family members and Control patients who have been treated with Interferon based therapy and already cleared of virus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To evaluate the Genotype and HCV sequencing (Phylogenetic analysis) of the virus affecting the family members 2. To determine the prevalence of HCV infection among family members of Index patients with HCV infection Timepoint: 4 Months for field visits, completion of questionnaire and collection of samples / results. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To identify the factors responsible for intrafamilial spread of HCV infection. 2. To determine phylogenetic similarity between Index patients and their infected Neighbours with no evidence of familial prevalence Timepoint: 4 Months for field visits, completion of questionnaire and collection of samples / results | — |
Countries
India